InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Merck & Co., Inc.. Officer active across 3 companies, notably Organon & Co.. Aggregated, 5 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €449.7m. Activity tracked since 11 March 2024. The latest transaction was disclosed on 11 March 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Merck & Co., Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
21,397,205 shares@ US$23.00100.0% of flowCommon Stock, par value $0.0001SEC:0000950170-24-029165:0
Canonical exit: 9 Jun 2024 (T+90)
253,516,000 sharesCommon StockSEC:0000899243-21-022060:0
18,518,519 sharesOrdinary SharesSEC:0001635698-16-000062:0
5,128,205 sharesOrdinary SharesSEC:0001635698-16-000062:1
7,942,314 sharesOrdinary SharesSEC:0001635698-16-000062:2
5 of 5 declarations
About Merck & Co., Inc.
Merck & Co., Inc. is a declarant with 6 filings in total. In the recent filings sampled, buys total 449728354 EUR, sells are 0 EUR, and the date range runs from 2016-02-10 to 2024-03-11. The companies mentioned are BeiGene, Ltd., Organon & Co., and Harpoon Therapeutics, Inc.
